Oppenheimer Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-38,191
| Closed | -$4.35M | – | 1200 |
|
|
2022
Q4 | $4.35M | Sell |
38,191
-700
| -2% | -$79.7K | 0.07% | 292 |
|
|
2022
Q3 | $2.41M | Sell |
38,891
-1,084
| -3% | -$67.1K | 0.04% | 408 |
|
|
2022
Q2 | $3.19M | Sell |
39,975
-1,785
| -4% | -$142K | 0.05% | 352 |
|
|
2022
Q1 | $4.39M | Sell |
41,760
-1,308
| -3% | -$138K | 0.06% | 319 |
|
|
2021
Q4 | $4.64M | Sell |
43,068
-676
| -2% | -$72.9K | 0.06% | 322 |
|
|
2021
Q3 | $4.79M | Sell |
43,744
-573
| -1% | -$62.8K | 0.07% | 307 |
|
|
2021
Q2 | $4.15M | Sell |
44,317
-1,160
| -3% | -$109K | 0.06% | 337 |
|
|
2021
Q1 | $4.19M | Buy |
45,477
+8,225
| +22% | +$757K | 0.06% | 322 |
|
|
2020
Q4 | $2.73M | Buy |
37,252
+8,197
| +28% | +$600K | 0.05% | 397 |
|
|
2020
Q3 | $2.26M | Sell |
29,055
-508
| -2% | -$39.5K | 0.04% | 404 |
|
|
2020
Q2 | $1.64M | Buy |
+29,563
| New | +$1.64M | 0.03% | 449 |
|
|
2017
Q3 | – | Sell |
-12,608
| Closed | -$150K | – | 1735 |
|
|
2017
Q2 | $150K | Sell |
12,608
-8,843
| -41% | -$105K | ﹤0.01% | 1101 |
|
|
2017
Q1 | $317K | Buy |
+21,451
| New | +$317K | 0.01% | 908 |
|